Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Kidney Cancer
Related studies linked through entity extraction aliases.
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
- Status
- UNKNOWN
- Phase
- N/A
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer
- Status
- COMPLETED
- Phase
- NA
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- NA
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast
- Status
- COMPLETED
- Phase
- PHASE1
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
- Status
- COMPLETED
- Phase
- PHASE4
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors
- Status
- WITHDRAWN
- Phase
- NA
MT2004-30: Tomotherapy for Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- N/A
Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2